Quick and easy test for viral infections reduces hospital admissions and antibiotic use

September 17, 2018, European Lung Foundation

A quick and easy test for viral infections can reduce unnecessary antibiotic use and hospital admissions, according to new research presented to the European Respiratory Society International Congress today (Monday).

The test, which takes just 50 minutes to obtain results, could save hospitals around €2,500 per patient not admitted to , would help to relieve winter pressures on available beds, and may help to reduce the development of .

Dr. Kay Roy, consultant physician in respiratory and general internal medicine at West Hertfordshire Hospitals NHS Trust, Watford, and honorary senior lecturer at the University of Hertfordshire, Hatfield (UK), told the congress: "Initial results on the first 1,075 patients, show the potential of this service. We were able to identify 121 patients who had viral infections, lacked any evidence of bacterial infection, had a normal chest X-ray and only modest indicators of inflammation. Of these, hospital admission was subsequently avoided in 25% and unnecessary were avoided in 50%. None of the 30 patients who avoided hospital admission and who were not prescribed antibiotics experienced adverse clinical outcomes, which is reassuring."

Point of care respiratory viral testing (POCT) is a new service that was launched at Watford General Hospital (UK) on 15 January 2018. It is quick and simple to perform; it involves inserting a swab into the patient's nostril to collect a sample of secretions from the back of the nose (1 minute); the sample is prepared and inserted into a compact machine called a FilmArray (3-5 minutes), which analyses the sample and then generates a printout within 43 minutes.

"The whole process from obtaining a sample from the patient's nose to getting a result should take under 50 minutes, which has a potentially enormous impact on quality of care, improving the patient journey by allowing earlier, informed decision-making about patient management," said Dr. Roy. "This is the same test and technology as used in our microbiology laboratory, but we have brought the equipment to the patient's bedside. Results from samples sent to the microbiology lab can take more than two days."

Dr. Roy presented data from the first 1075 patients between 15 January and 1 May 2018 to the congress. Of these, 61% showed the patients had one or more viruses, of which 56% were influenza and 54% were other viruses, such as rhinovirus, coronavirus, metapneumovirus and adenovirus, which can cause just as many respiratory and other problems as 'flu or a bacterial infection, particularly in patients with chronic obstructive pulmonary disease (COPD).

The results of the tests were combined with other important clinical factors, such as chest X-ray findings and lack of evidence of bacterial infection, in 387 patients. From these, 121 patients were identified who were potentially suitable for avoiding hospital admission and antibiotics.

"We found that when patients had point of care respiratory viral testing soon after they were admitted to the emergency department, bed flow improved and fewer bed closures were required due to viral infections. This is extremely valuable during winter bed pressures, especially during an influenza epidemic.

"In the first two weeks of this new service we diagnosed 50 cases of influenza: 22 by testing in the emergency department and 28 after patients were admitted. There were no bed moves in the former group but 14 in the latter, demonstrating that earlier bedside testing in the improves infection control, thereby avoiding bed and ward closures and reducing the risk of spreading infection to vulnerable groups. Infected patients with POCT-based early diagnosis of influenza can be admitted to appropriately designated beds if admission is required," she said.

The cost of POCT is offset by avoiding, for example, the cost of the microbiology laboratory testing and the cost of admitting patients to hospital beds. "The findings clearly point towards a net cost saving. Each respiratory admission can cost around £2000 (€2,500). We could make a significant saving for national health services by avoiding unnecessary admissions in patients who may have otherwise been admitted and given antibiotics while waiting up to two days for results from the lab. Patients in whom antibiotics were avoided also contribute to cost savings, as do the beds and wards which remain open," said Dr. Roy.

She is about to start a randomised controlled trial in the community, in which primary care physicians (GPs) will be able to refer patients to a community hub for POCT, with respiratory physicians available to support the GPs.

"The frequent underestimation of the role of viruses in respiratory admissions, both in previously well patients and those with chronic underlying disease such as COPD, has hindered good antimicrobial stewardship," said Dr. Roy. "This has sometimes led to other health problems for patients from inappropriate antibiotic use and hospital admission. We hope that quality of patient care can be improved with POCT for respiratory viruses, as well as helping to reduce the development of antibiotic resistance."

Professor Tobias Welte, from Hannover University, Germany, is President-Elect of the European Respiratory Society and was not involved in the study. He said: "As European populations age, there is increasing pressure on the availability of hospital beds. Having to close a ward because a patient has been admitted with a viral infection that could spread to other patients and is not treatable with antibiotics places even more pressure on hospitals, as well as being expensive. The innovative approach described in this presentation could make a significant difference not only to hospitals but also to , whose quality of life will be much improved by avoiding unnecessary antibiotic use and admittance to hospital. However, this test will have to be compared to guidelines and recommended best clinical practice to confirm its usefulness."

Explore further: Infection blood test of limited value in reducing antibiotic use

More information: Abstract no: PA2032, "Point of care respiratory viral testing (POCT): A novel service to target appropriate antimicrobial prescription and improve antibiotic stewardship", by Kay Roy et al; "Improving the outcomes of community-acquired pneumonia", poster discussion session, 08.30-10.30 hrs CEST, Monday 17 September, Room 7.2C.

Related Stories

Infection blood test of limited value in reducing antibiotic use

May 21, 2018
Overall antibiotic use was not curbed by giving physicians the results of biomarker tests in patients with suspected lower respiratory tract infections, according to findings from the Procalcitonin Antibiotic Consensus Trial ...

Infection blood test of limited value in cutting antibiotics

May 23, 2018
Overall antibiotic use was not curbed by giving physicians the results of biomarker tests in patients with suspected lower respiratory tract infections, according to findings from the Procalcitonin Antibiotic Consensus Trial ...

Negative rapid test results may delay antiviral therapy in patients with severe influenza

June 10, 2018
A new study has found that half of influenza cases in patients admitted to the intensive care unit (ICU) received a false negative rapid influenza antigen test (RIAT). The false negative RIAT results could delay antiviral ...

Researchers develop novel flu test to speed up respiratory treatment

April 5, 2017
Developed by Dr Tristan Clark, an associate professor in infectious diseases at the University of Southampton and colleagues at the NIHR Southampton Biomedical Research Centre, the 'point-of-care' testing strategy can be ...

Four simple tests could help GPs spot pneumonia and reduce unnecessary antibiotics

November 23, 2017
Testing for fever, high pulse rate, crackly breath sounds, and low oxygen levels could be key to helping GPs distinguish pneumonia from less serious infections, according to a large study published in the European Respiratory ...

Antibiotics: On-the-spot tests reduce unnecessary prescriptions

November 5, 2014
Fast, on-the-spot tests for bacterial infections may help to reduce excessive antibiotic use. A systematic review published in The Cochrane Library, found that when doctors tested for the presence of bacterial infections ...

Recommended for you

Marker may help target treatments for Crohn's patients

October 16, 2018
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents ...

Study traces hospital-acquired bloodstream infections to patients' own bodies

October 15, 2018
The most common source of a bloodstream infection acquired during a hospital stay is not a nurse's or doctor's dirty hands, or another patient's sneeze or visitor's cough, but the patient's own gut, Stanford University School ...

Polio: Environmental monitoring will be key as world reaches global eradication

October 15, 2018
Robust environmental monitoring should be used as the world approaches global eradication of polio, say University of Michigan researchers who recently studied the epidemiology of the 2013 silent polio outbreak in Rahat, ...

Researchers make essential imaging tests safer for people at risk of acute kidney injury

October 15, 2018
Every year, millions of people undergo medical tests and procedures, such as coronary angiography, which use intravascular contrast dyes. "For the majority of patients, these are safe and necessary procedures. However, about ...

Medical marijuana might help MS patients, but uncertainty remains

October 13, 2018
Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients.

Do not give decongestants to young children for common cold symptoms, say experts

October 11, 2018
Decongestants should not be given to children under 6—and given with caution in children under 12—as there is no evidence that they alleviate symptoms such as a blocked or runny nose, and their safety is unclear, say ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.